Pharmaceutical Executive February 14, 2025
James Foster, CEO and co-founder of Virax Biolabs, discusses how the industry is preparing for potential regulatory changes to vaccine policy.
Pharmaceutical Executive: Due to recent political turbulence, many companies feel like they are facing uncertain regulatory environments. How can they strategize for that?
James Foster: We’re, relatively speaking, a small firm, so we’re able to stay nimble. As a result of that, we can move with the punches, so to speak. But I think a lot of from an executive perspective, and the way that we have to look at things is you have to strategize around particular events potentially occurring.
This tariff event, if we want to talk about that specifically, is something that we’ve strategized over the past...